PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX ...
PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, ...
Aligos Therapeutics: Promising Pipeline With Cash And Dilution Risks
Aligos Therapeutics focuses on ALG-000184 for CHB and ALG-055009 for MASH, targeting large, underserved markets with growing ...
unige.ch14 小时
Development of Broad-Spectrum β-Cyclodextrins-Based Nanomaterials Against Influenza Viruses
Zwygart AC, Medaglia C, Zhu Y, Bart Tarbet E, Jonna W, Fage C, Le Roy D, Roger T, Clément S, Constant S, Huang S, Stellacci F, Silva PJ, Tapparel C. Development of Broad-Spectrum β-Cyclodextrins-Based ...